La’Ron Browne: Balancing Clinical Benefits and Healthcare Costs in Hydroxyurea Management of SCD in Brazil
La’Ron Browne, Instructor at St. Jude Children’s Research Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Global Hematology, adding:
”I am pleased to announce that our paper on Hydroxyurea therapy in Sickle Cell Disease (SCD): Evaluating healthcare costs and use in a Brazilian tertiary setting has been shortlisted by Blood Global Hematology for impactful manuscripts.
In our study, we highlight that while hydroxyurea (HU) decreased acute utilization in patients with SCD, it did not reduce overall healthcare costs.
The likely drivers of the total health costs were persistent chronic care management, decreased adherence, and later initiation of hydroxyurea.
These findings are important for many low- and middle-income countries (LMIC) and upper-middle-income countries (UMIC) to initiate conversations about implementing hydroxyurea early in life, which can help mitigate the long-standing costs associated with chronic diseases like SCD.”
Title: Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting
Authors: La’Ron L. A. Browne, Emilia Matos do Nascimento, Patricia Moura, Delaine Fidlarczyk, Jane Duran, Roberto Barbosa, Thais Oliveira, George Goshua, Jane S. Hankins, Clarisse Lobo
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment